Dyno Therapeutics Emerges With Novartis, Sarepta Deals For Novel AAV Capsids

 
• By Mandy Jackson
  
Adeno-associated virus serotype 1. Virus is used as a vector for gene therapy
Dyno's novel AAV capsids could expand gene therapy's reach • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Business